RegentAtlantic Capital’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.56M Buy
8,427
+2,553
+43% +$505K 0.05% 239
2022
Q2
$1.05M Buy
5,874
+1,918
+48% +$490K 0.03% 305
2022
Q1
$1.34M Buy
3,956
+1,110
+39% +$375K 0.04% 276
2021
Q4
$1.05M Sell
2,846
-524
-16% -$199K 0.03% 318
2021
Q3
$1.33M Buy
3,370
+870
+35% +$400K 0.04% 261
2021
Q2
$1.15M Buy
2,500
+846
+51% +$341K 0.04% 275
2021
Q1
$618K Buy
+1,654
New +$674K 0.02% 351
2019
Q1
Sell
-797
Closed -$232K 435
2018
Q4
$232K Buy
797
+70
+10% +$21.7K 0.02% 372
2018
Q3
$260K Buy
+727
New +$233K 0.02% 385

Other funds holding ILMN

RegentAtlantic Capital's ILMN Position: Q3 2022 in Review

RegentAtlantic Capital increased its Illumina (ILMN) stake by 43% in Q3 2022, buying an estimated $505K and bringing the position to 8,427 shares worth $1.56M. The position accounts for 0.05% of the portfolio, ranked #239.

RegentAtlantic Capital first reported a position in ILMN in Q3 2018 and has held it in 9 quarters since. 897 funds tracked by Wall St. Rank hold ILMN as of Q3 2022.

  • RegentAtlantic Capital held 8,427 shares of Illumina worth $1.56M as of Q3 2022.
  • RegentAtlantic Capital bought 2,553 Illumina shares in Q3 2022, an estimated $505K.
  • Illumina made up 0.05% of RegentAtlantic Capital's portfolio in Q3 2022, its #239 holding.
  • RegentAtlantic Capital first reported a position in Illumina in Q3 2018 and has held it in 9 quarters since.
  • 897 funds tracked by Wall St. Rank held Illumina as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.